---
title: "Kanion Pharmaceutical: Obtained the drug registration certificate for Yunu Jian granules"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237694234.md"
description: "Kanion Pharmaceutical recently obtained the drug registration certificate for Yunu Jian granules issued by the National Medical Products Administration. This drug is a unique variety of traditional Chinese medicine category 3.1, mainly used for clearing stomach heat and nourishing kidney yin. The drug has a shelf life of 24 months, with the registration standard number YBZ00102025 and the approval number Guo Yao Zhun Zi C20250006. The company's investment in the research and development of this project is approximately 6.01 million yuan, and its approval will enhance market competitiveness and brand influence"
datetime: "2025-04-27T08:52:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237694234.md)
  - [en](https://longbridge.com/en/news/237694234.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237694234.md)
---

# Kanion Pharmaceutical: Obtained the drug registration certificate for Yunu Jian granules

Kanion Pharmaceutical announced that the company recently received the "Drug Registration Certificate" for Yu Nu Jian Granules issued by the National Medical Products Administration. The main ingredients of this medicine include gypsum, cooked rehmannia, ophiopogon, and anemarrhena, with a dosage form of granules, each bag containing 8g. It is classified as a Category 3.1 traditional Chinese medicine and is an exclusive variety. The function and indications of Yu Nu Jian Granules are to clear stomach heat and nourish kidney yin, used for stomach heat and yin deficiency syndrome, with symptoms such as headache, toothache, loose teeth, and gingival bleeding. The shelf life of the medicine is 24 months, and it is a prescription drug. The drug registration standard number is YBZ00102025, and the drug approval number is Guo Yao Zhun Zi C20250006. The manufacturing company is Jiangsu Kanion Pharmaceutical Co., Ltd. As of the announcement date, the company has invested approximately 6.01 million yuan in the research and development of the Yu Nu Jian Granules project. The approval for the production and market launch of Yu Nu Jian Granules will enrich the company's product lineup and enhance its market competitiveness and brand influence

### Related Stocks

- [600557.CN](https://longbridge.com/en/quote/600557.CN.md)
- [562390.CN](https://longbridge.com/en/quote/562390.CN.md)

## Related News & Research

- [China’s Coal Prices Surge as Scorching Heat Drives Power Demand](https://longbridge.com/en/news/294348778.md)
- [Shein will struggle to justify $40-50 billion Hong Kong IPO valuation](https://longbridge.com/en/news/293916514.md)
- [Venice Token: Grok Imagine 1.5 becomes available privately on Venice - 01 Aug 2026](https://longbridge.com/en/news/294571963.md)
- [Asia Naphtha/Gasoline-Naphtha prices gain amid renewed U.S.-Iran tensions](https://longbridge.com/en/news/294346186.md)
- [METALS-Copper drifts lower ahead of Fed rate decision](https://longbridge.com/en/news/294148192.md)